Skip to main content

Advertisement

SpringerLink
Log in

Valuing Children’s Health

Whose Quality of Life Matters?

  • Commentary
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Neumann PJ. What next for QALYs? JAMA 2011 May; 305(17): 1806–7

    Article  PubMed  CAS  Google Scholar 

  2. Stevens K. Valuation of the Child Health Utility 9D Index. Pharmacoeconomics 2012; 30(8): 729–47

    Article  PubMed  Google Scholar 

  3. Ratcliffe J, Flynn T, Terlich F, et al. Developing adolescentspecific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D. Pharmacoeconomics 2012; 30(8): 713–27

    Article  PubMed  Google Scholar 

  4. Stevens K. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual Life Res 2009 Oct; 18(8): 1105–13

    Article  PubMed  Google Scholar 

  5. Wille N, Badia X, Bonsel G, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res 2010; 19(6): 875–86

    Article  PubMed  Google Scholar 

  6. Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 2003 Sep; 12(6): 599–607

    Article  PubMed  Google Scholar 

  7. Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996

    Google Scholar 

  8. Nord E. Cost-value analysis in health care: making sense out of QALYs. New York: Cambridge University Press, 1999

    Google Scholar 

  9. Ungar WJ. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated? Pharmacoeconomics 2011 Aug; 29(8): 641–52

    Article  PubMed  Google Scholar 

  10. Basu A, Meltzer D. Implications of spillover effects within the family for medical cost-effectiveness analysis. J Health Econ 2005 Jul; 24(4): 751–73

    Article  PubMed  Google Scholar 

  11. Davidson T, Levin LA. Is the societal approach wide enough to include relatives? Incorporating relatives’ costs and effects in a cost-effectiveness analysis. Appl Health Econ Health Policy 2010; 8(1): 25–35

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The author has no conflicts of interest that are directly relevant to the content of this article and the opinions expressed are the author’s own.

This paper is part of a theme issue co-edited by Lisa Prosser, University of Michigan, USA, and no external funding was used to support the publication of this theme issue.

Author information

Authors and Affiliations

  1. Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Ave., 2nd floor, Boston, Massachusetts, MA 02115, USA

    Eve Wittenberg

Authors
  1. Eve Wittenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eve Wittenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wittenberg, E. Valuing Children’s Health. PharmacoEconomics 30, 633–635 (2012). https://doi.org/10.2165/11632490-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11632490-000000000-00000

Keywords

Search

Navigation